Target intelligence / Profile preview

Sialic acid residue (host cell surface)

Molecular classification
Other (terminal monosaccharide/glycoconjugate), Glycan modification
01

Overview

Sialic acid residues are negatively charged, nine-carbon monosaccharides most commonly found as terminal modifications on glycoproteins and glycolipids on the outer surface of vertebrate cell membranes[1][2]. These residues play diverse roles including mediating cell-cell recognition, stabilizing glycoprotein structure, regulating immune responses (such as complement pathway and Siglec interactions), supporting neural development, and modulating cell adhesion[2][3][5]. Pathogens—including viruses (e.g., influenza), bacteria, and protozoa—exploit sialic acid residues to bind and invade host cells, often contributing to infection and immune evasion, a phenomenon called molecular mimicry[3][4][6]. Sialylation levels on the cell surface dynamically affect physiological processes such as inflammation, neuronal signaling, and cancer metastasis by altering cell repellency, immune cell trafficking, and masking of antigenic sites[1][2][3][4]. However, "host cell surface sialic acid residues" describes a common cell surface feature (a chemical modification), not a discrete protein or conventional therapeutic target, rendering direct drug targeting inappropriate and likely unsafe[2][4]. Summary: - "Host cell surface sialic acid residues" refers to a common terminal sugar modification, not a canonical receptor, protein, or established therapeutic target. - Many pathogens exploit these glycans for host entry but drugs do not directly target these residues because of their ubiquity and essential cellular functions. - Sialylation patterns in disease may serve as biomarkers, especially for cancer and infection. - Targeting strategies focus on blocking pathogen interaction or modulating related signaling pathways, not on the residues themselves.

Other names
Sialic acidN-acetylneuraminic acid residueNeu5Ac residueHost cell sialic acidTerminal sialylated glycan
02

Mechanism of action

Not applicable for traditional drug targeting; most interest is in the mechanism of viral or microbial attachment (e.g., influenza hemagglutinin binds α2,6- or α2,3-linked sialic acid for entry)

03

Biological functions

Cell-cell recognitionSignal transductionImmune modulation (complement regulation, Siglec/selectin binding)Cell adhesion/anti-adhesionProtein stability and turnoverPathogenesis (infection, immune evasion)Water retention on cell surfaceBrain development and cognitive function
04

Disease associations

Infection (viral and bacterial attachment, e.g., influenza, *Toxoplasma gondii*)Cancer (metastasis/facilitates cell detachment and migration)Immune disorders (modulation of complement and phagocytosis)Inflammatory diseaseOther (microbial pathogenesis, immune evasion)
05

Safety considerations

Not a druggable target; disruption could have broad effects including compromised immune self-recognition (increased autoimmune risk)Sialic acid removal exposes cryptic antigens, triggering unwanted immune responses or clearanceTargeting would have high risk of off-target effects due to universal presence in mammalian cells
06

Interacting drugs

None specific; however, viral hemagglutinins (e.g., from influenza viruses) and some microbial adhesins/treatment strategies may target sialic acid residues but these are not drugs against host sialic acid, rather viral or bacterial proteins exploiting this host feature
07

Biomarkers

Sialic acid content/density (used as a biomarker in some cancers and inflammatory diseases for prognosis and diagnosis)Sialylated glycoproteins (e.g., increased sialylation in bloodstream may indicate tumor progression or inflammation)

Beyond the preview

Go deeper on Sialic acid residue (host cell surface).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sialic acid residue (host cell surface).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call